Circ Cardiovasc Qual Outcomes

Slides:

Advertisements

Similar presentations

The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.

Advertisements

1 Cardiovascular Disease in Asia. WHO CVD Atlas WHO Stroke Atlas The Burden of CVD in Asia: Stroke Deaths by Country,

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):

Algorithm for guideline-directed medical therapy for patients with stable ischemic heart disease. The use of bile acid sequestrant is relatively contraindicated.

Revascularisation myocardique complexe 5ème Congrès de la SMAC

Algorithm for the management of aortic valve stenosis

Renal Artery Stenosis: When to Revascularize in 2017

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Nat. Rev. Cardiol. doi: /nrcardio

Prostate cancer mortality as a factor of Gleason score and age at diagnosis in men managed conservatively. (Adapted, with permission, from Albertsen PC.

The anatomical results of patients classified as having a low, intermediate, or high probability of developing three-vessel or left main coronary artery.

Chest radiograph cardiac enlargement, with prominence of the pulmonary artery, right atrium, and right ventricle, in a patient with primary pulmonary hypertension.

Circ Cardiovasc Qual Outcomes

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)‏

Circ Cardiovasc Qual Outcomes

Circ Arrhythm Electrophysiol

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.

Complexities of Genetic Testing in Familial Dilated Cardiomyopathy

by Mario Gössl, Garvan C. Kane, William Mauermann, and David R. Holmes

Sex-Related Differences in Fractional Flow Reserve–Guided Treatment

Value-Based Hypothesis Testing for Cardiac Device Clinical Trials

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Behavior and Biology: The Basic Sciences for AHA Action

Physician and Patient Influences on Provider Performance

Circ Cardiovasc Qual Outcomes

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Circ Cardiovasc Qual Outcomes

Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,

Effect of Provider Volume on the Accuracy of Hospital Report Cards

New Frontiers in Cardiology

Circ Cardiovasc Imaging

Iatrogenic Adverse Events in the Coronary Care Unit

Statin Treatment and Functional Outcome After Ischemic Stroke

by Johan Denollet, Angélique A. Schiffer, and Viola Spek

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Mathematical representation of Bayes theorem.

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

by Clarisse Toledo, George Thomas, Jesse D

Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,

The Process of Rehabilitation and Discharge Planning in Stroke

Using the Coronary Artery Calcium Score to Guide Statin Therapy

by Peter J. Schwartz, Maria Teresa La Rovere, Gaetano M

Circ Cardiovasc Interv

Fractional Flow Reserve Returns to Its Origins

Catheter-Based Treatment of Coronary Artery Disease

More Than Survival: Futility

Metabolic Complications in Elderly Adults With CKD

Figure 8 4D magnetic resonance imaging patterns

Eric Peterson Journal of Indian College of Cardiology

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

A New Era of Renal Denervation Trials for Patients With Hypertension?

Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

Efficacy outcomes in patients aged ≥65 years versus younger patients: ACR outcomes at (A) week 12 and (B) week 24. Efficacy outcomes in patients aged ≥65.

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

David A. Goodkin, MD, Eric W

Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.

Glenn N. Levine et al. JACC 2011;58:e44-e122

In the Literature: Cognitive Impairment in Hemodialysis Patients

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect.

Presentation transcript:

Circ Cardiovasc Qual Outcomes Frailty Trajectories After Treatment for Coronary Artery Disease in Older Patients by Elizabeth A. Freiheit, David B. Hogan, Scott B. Patten, Hannah Wunsch, Todd Anderson, William A. Ghali, Merril Knudtson, and Colleen J. Maxwell Circ Cardiovasc Qual Outcomes Volume 9(3):230-238 May 17, 2016 Copyright © American Heart Association, Inc. All rights reserved.

Calgary Cardiac and Cognition (3C) study flow. Calgary Cardiac and Cognition (3C) study flow. Reproduced from Freiheit et al26 with permission of the publisher. Copyright © (2012) American Medical Association. All rights reserved. Elizabeth A. Freiheit et al. Circ Cardiovasc Qual Outcomes. 2016;9:230-238 Copyright © American Heart Association, Inc. All rights reserved.

Mean frailty index scores over time by (A) sex, (B) baseline age category, (C) treatment group, and (D) treatment group and baseline age. Mean frailty index scores over time by (A) sex, (B) baseline age category, (C) treatment group, and (D) treatment group and baseline age. Elizabeth A. Freiheit et al. Circ Cardiovasc Qual Outcomes. 2016;9:230-238 Copyright © American Heart Association, Inc. All rights reserved.